Eris Lifesciences is trading -0.38% lower at Rs 1,783.50 as compared to its last closing price. Eris Lifesciences has been trading in the price range of 1,815.80 & 1,734.55. Eris Lifesciences has given 30.39% in this year & 8.43% in the last 5 days. Eris Lifesciences has TTM P/E ratio 54.75 as compared to the sector P/E of 24.72.There are 9 analysts who have initiated coverage on Eris Lifesciences. There are 5 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 93.84 Crores in its last quarter.Listed peers of Eris Lifesciences include J B Chemicals And Pharmaceutical (-1.44%), Wockhardt (-0.35%), Eris Lifesciences (-0.38%).The Mutual Fund holding in Eris Lifesciences was at 16.59% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Eris Lifesciences was at 8.43% in 31 Mar 2025. The FII holding has increased from the last quarter.
Updated on Jun 13, 2025, 03:52 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
J B Chemicals And Pharmaceutical | Moderately Bullish | 1,720.00 | -1.44 | 26,749.56 | 40.13 | 7.56 | 0.73 | 0.19 |
Wockhardt | Bullish | 1,777.45 | -0.35 | 28,879.83 | - | 5.76 | - | 30.00 |
Eris Lifesciences | Bullish | 1,783.50 | -0.38 | 24,380.65 | 65.54 | 8.07 | 0.43 | 62.42 |
Alembic Pharmaceuticals | Moderately Bullish | 997.65 | 0.70 | 19,661.45 | 33.72 | 3.72 | 1.12 | 0.90 |
Jubilant Pharmova | Bullish | 1,094.15 | -2.78 | 17,395.08 | 34.17 | 2.9 | 0.44 | 38.19 |
Meeting Date | Purpose |
---|---|
2025-05-19 | Audited Results |
2025-02-07 | Interim Dividend |
2025-02-04 | Quarterly Results |
2024-10-25 | Quarterly Results |
2024-08-02 | Quarterly Results |
Eris Lifesciences is trading at 1783.50 as on Fri Jun 13 2025 09:59:35. This is -0.38% lower as compared to its previous closing price of 1790.25.
The market capitalization of Eris Lifesciences is 24380.65 Cr as on Fri Jun 13 2025 09:59:35.
The average broker rating on Eris Lifesciences is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Eris Lifesciences is 1909.55 whereas the 52 wk low is 988.95
Eris Lifesciences can be analyzed on the following key metrics -
Eris Lifesciences reported a net profit of 351.84 Cr in 2025.
The Mutual Fund Shareholding was 16.59% at the end of 31 Mar 2025.